Obstetrícia/Medicina Fetal

FDA alerta para os riscos associados aos testes de rastreamento pré-natal não invasivos – interpretação inadequada dos resultados pode levar a potenciais decisões médicas impróprias.

21 Abr, 2022 | 12:27h

FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests – U.S. Food & Drug Administration

Ver também: Genetic Non-Invasive Prenatal Screening Tests May Have False Results: FDA Safety Communication – U.S. Food & Drug Administration

---

Revisão | Ruptura prematura de membranas – Tratamento em ambiente hospitalar vs. ambulatorial.

21 Abr, 2022 | 11:56h

Preterm Premature Rupture of Membranes – Inpatient Versus Outpatient Management: an Evidence-Based Review – Geburtshilfe und Frauenheilkunde

---

M-A | Doença invasiva por estreptococo do grupo A em gestantes e crianças pequenas.

21 Abr, 2022 | 11:55h

Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis – The Lancet Infectious Diseases

Comentário convidado: Recognising group A streptococcal disease in pregnancy – The Lancet Infectious Diseases (necessário cadastro gratuito)

---

Revisão sistemática | Doses repetidas de corticosteroides no pré-natal de mulheres em risco de parto prematuro para melhorar os desfechos neonatais de saúde.

21 Abr, 2022 | 11:53h

Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes – Cochrane Library

Resumo: Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving health outcomes in their babies – Cochrane Library

---

Revisão de escopo de políticas globais, diretrizes e literatura | Preparação e prontidão para alta pós-parto.

18 Abr, 2022 | 15:05h

Discharge preparation and readiness after birth: a scoping review of global policies, guidelines and literature – BMC Pregnancy & Childbirth

Conteúdos relacionados:

WHO recommendations on maternal and newborn care for a positive postnatal experience.

Putting positive experiences at the center of postnatal care.

---

M-A | Desfechos perinatais adversos associados com terapia antirretroviral baseada em inibidor de protease em gestantes vivendo com HIV.

14 Abr, 2022 | 17:32h

Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis – EClinicalMedicine

Comunicado de imprensa: Protease inhibitors safer than thought for pregnant women with HIV – University of Oxford

---

Estudo de caso-controle e teste negativo | Vacina CoronaVac mostrou-se efetiva em evitar COVID-19 grave e sintomática em gestantes no Brasil.

12 Abr, 2022 | 12:37h

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study – BMC Medicine

---

Experiências positivas no centro da atenção pós-natal.

11 Abr, 2022 | 12:54h

Putting positive experiences at the centre of postnatal care – Evidently Cochrane Blog

Diretriz original: WHO recommendations on maternal and newborn care for a positive postnatal experience.

---

#ACC22 – Estudo randomizado | Tratamento para hipertensão crônica leve durante a gestação está associada com melhores desfechos gestacionais do que a estratégia de tratamento reservado somente para hipertensão grave.

5 Abr, 2022 | 12:25h

Treatment for Mild Chronic Hypertension during Pregnancy – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Treating chronic hypertension in early pregnancy benefits parents, babies – NIH News Releases

CHAP: Treating Mild Chronic HTN is Associated With Better Pregnancy Outcomes – American College of Cardiology

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes – TCTMD

 

Comentário no Twitter

In pregnant women with mild chronic hypertension, targeting a blood pressure of < 140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension. #ACC22 https://t.co/fDrqa8uQiO pic.twitter.com/9KvogjnKcc

— NEJM (@NEJM) April 2, 2022

 

---

M-A | Estimativas globais da prevalência e progressão da retinopatia diabética em gestantes com diabetes pré-existente.

5 Abr, 2022 | 11:46h

Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis – JAMA Ophthalmology (gratuito por tempo limitado)

Comentário convidado: Diabetic Retinopathy in Pregnancy – JAMA Ophthalmology (gratuito por tempo limitado)

 

Comentário no Twitter

In this study, higher #diabeticretinopathy (DR) prevalences were found in pregnant women with pre-existing #diabetes compared w non-pregnant women. Women with T2D compared w T1D were not noted to have a different risk of DR progression during pregnancy. https://t.co/lfTi9kIBTj

— JAMAOphthalmology (@JAMAOphth) April 1, 2022

 

---